Cargando…

Use of deferred consent for severely ill children in a multi-centre phase III trial

BACKGROUND: Voluntary participation of a subject in research respects a subject's rights, strengthens its ethical conduct, and is formalized by the informed consent process. Clinical trials of life-saving interventions for medical emergencies often necessitate enrolment of patients where prior...

Descripción completa

Detalles Bibliográficos
Autores principales: Maitland, Kathryn, Molyneux, Sassy, Boga, Mwamvua, Kiguli, Sarah, Lang, Trudie
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077324/
https://www.ncbi.nlm.nih.gov/pubmed/21453454
http://dx.doi.org/10.1186/1745-6215-12-90
_version_ 1782201864312324096
author Maitland, Kathryn
Molyneux, Sassy
Boga, Mwamvua
Kiguli, Sarah
Lang, Trudie
author_facet Maitland, Kathryn
Molyneux, Sassy
Boga, Mwamvua
Kiguli, Sarah
Lang, Trudie
author_sort Maitland, Kathryn
collection PubMed
description BACKGROUND: Voluntary participation of a subject in research respects a subject's rights, strengthens its ethical conduct, and is formalized by the informed consent process. Clinical trials of life-saving interventions for medical emergencies often necessitate enrolment of patients where prior written individual informed consent is impossible. Although there are regulations and guidelines on protecting subjects in emergency research, these have been criticised for being limited and unnecessarily restrictive. Across Europe and the United States stringent regulations have resulted in a substantial decline of clinical trials involving emergency interventions. METHODS: We are conducting a trial of fluid resuscitation in children with hypovolaemic shock in six hospitals across three malaria-endemic African countries. The design is pragmatic as children are enrolled on clinical criteria alone and is being conducted in hospitals with facilities typical of many district hospitals across Africa. The trial aims to inform strategy for managing children with febrile illness and features of shock. In order to develop appropriate consent processes for the trial, we conducted a narrative review of current international recommendations for emergency consent. RESULTS: Practical or specific guidance was generally sparse or confusing with few examples in the literature to direct our informed consent process. For a sub-group of children who were critically sick or where parents themselves were otherwise too distressed to consider prior written consent, we opted for a modified form of deferred consent. This included verbal assent from guardians at the point of enrolment, with full written consent obtained after stabilising the child. For children who died prior to full written consent, ethical permission was received to waiver full consent. CONCLUSIONS: In light of the controversy around guidance and regulations in this area we report how and why we have used a modified system of deferred consent in an emergency intervention trial in children. Although approved by all relevant ethics committees and operational in 3 countries in Africa, formal research is now necessary to explore the perceptions and experiences of parents, health workers, researchers and ethics committees of the modified method of deferred consent.
format Text
id pubmed-3077324
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30773242011-04-15 Use of deferred consent for severely ill children in a multi-centre phase III trial Maitland, Kathryn Molyneux, Sassy Boga, Mwamvua Kiguli, Sarah Lang, Trudie Trials Methodology BACKGROUND: Voluntary participation of a subject in research respects a subject's rights, strengthens its ethical conduct, and is formalized by the informed consent process. Clinical trials of life-saving interventions for medical emergencies often necessitate enrolment of patients where prior written individual informed consent is impossible. Although there are regulations and guidelines on protecting subjects in emergency research, these have been criticised for being limited and unnecessarily restrictive. Across Europe and the United States stringent regulations have resulted in a substantial decline of clinical trials involving emergency interventions. METHODS: We are conducting a trial of fluid resuscitation in children with hypovolaemic shock in six hospitals across three malaria-endemic African countries. The design is pragmatic as children are enrolled on clinical criteria alone and is being conducted in hospitals with facilities typical of many district hospitals across Africa. The trial aims to inform strategy for managing children with febrile illness and features of shock. In order to develop appropriate consent processes for the trial, we conducted a narrative review of current international recommendations for emergency consent. RESULTS: Practical or specific guidance was generally sparse or confusing with few examples in the literature to direct our informed consent process. For a sub-group of children who were critically sick or where parents themselves were otherwise too distressed to consider prior written consent, we opted for a modified form of deferred consent. This included verbal assent from guardians at the point of enrolment, with full written consent obtained after stabilising the child. For children who died prior to full written consent, ethical permission was received to waiver full consent. CONCLUSIONS: In light of the controversy around guidance and regulations in this area we report how and why we have used a modified system of deferred consent in an emergency intervention trial in children. Although approved by all relevant ethics committees and operational in 3 countries in Africa, formal research is now necessary to explore the perceptions and experiences of parents, health workers, researchers and ethics committees of the modified method of deferred consent. BioMed Central 2011-03-31 /pmc/articles/PMC3077324/ /pubmed/21453454 http://dx.doi.org/10.1186/1745-6215-12-90 Text en Copyright ©2011 Maitland et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology
Maitland, Kathryn
Molyneux, Sassy
Boga, Mwamvua
Kiguli, Sarah
Lang, Trudie
Use of deferred consent for severely ill children in a multi-centre phase III trial
title Use of deferred consent for severely ill children in a multi-centre phase III trial
title_full Use of deferred consent for severely ill children in a multi-centre phase III trial
title_fullStr Use of deferred consent for severely ill children in a multi-centre phase III trial
title_full_unstemmed Use of deferred consent for severely ill children in a multi-centre phase III trial
title_short Use of deferred consent for severely ill children in a multi-centre phase III trial
title_sort use of deferred consent for severely ill children in a multi-centre phase iii trial
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3077324/
https://www.ncbi.nlm.nih.gov/pubmed/21453454
http://dx.doi.org/10.1186/1745-6215-12-90
work_keys_str_mv AT maitlandkathryn useofdeferredconsentforseverelyillchildreninamulticentrephaseiiitrial
AT molyneuxsassy useofdeferredconsentforseverelyillchildreninamulticentrephaseiiitrial
AT bogamwamvua useofdeferredconsentforseverelyillchildreninamulticentrephaseiiitrial
AT kigulisarah useofdeferredconsentforseverelyillchildreninamulticentrephaseiiitrial
AT langtrudie useofdeferredconsentforseverelyillchildreninamulticentrephaseiiitrial